Laser Verses Conventional Circumferential Supracrestal Fiberotomy in Orthodontic Extrusion for Crown Lengthening

February 25, 2024 updated by: roquaiya eldardear, Cairo University

Laser Verses Conventional Circumferential Supracrestal Fiberotomy in Orthodontic Extrusion for Crown Lengthening: A Randomized Controlled Clinical Trial

The aim of this study is to the evaluate the stability of the amount of healthy tooth structure exposed after laser versus conventional technique of fiberotomy during orthodontic extrusion.

Study Overview

Detailed Description

Parallel groups, two arm, superiority Randomized Controlled Clinical Trial, with 1:1 allocation.

PICO:

Population: patients with endodontically treated teeth and short clinical crown that require crown lengthening in the esthetic zone Intervention: laser fiberotomy with orthodontic extrusion Control: conventional fiberotomy using blade with orthodontic extrusion

Outcomes:

Primary outcome: Stability of the mount of healthy tooth structure exposed.

Secondary outcomes:

  • Stability of gingival Margin reference.
  • Stability of the alveolar bone.
  • Rate of tooth extrusion.
  • Sulcus depth.
  • Pain Time: 8 weeks after retention

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age between 18 and 50 years old
  • Teeth in the esthetic zone
  • Restorable teeth with successful endodontic treatment
  • Adjacent teeth with clinical attachment of at least two-thirds of the root length, thus permitting adequate support for orthodontic movement
  • Crown root ratio after extrusion of the needed ferrule amount not less than 1:1

Exclusion Criteria:

  • Patients with bad oral hygiene or Periodontally affected teeth
  • Uncontrolled diabetic patients
  • Pregnant females
  • Medications that could affect tooth movement (bisphosphonate) radiation therapy less than 2 years
  • Moderate-to-heavy daily smokers (who report consuming at least 11 cigarettes/day)
  • Teeth with periapical inflammation, ankylosis or vertical root fracture
  • Teeth with probability of furcation exposure after extrusion.
  • The level of the root is 3 mm or more apical to the level of the bone

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: conventional circumferential supracrestal fiberotomy
  • The amount of tooth that need to be extruded will be measured Bonding brackets slot 0,022"x0.028" Roth prescription on piggyback for the tooth with (0.016". x 0.022 ") stainless steel main arch wire and 0.0014" nickel titanium auxiliary.

    • Fiberotomy After 2 days of bonding, local anaesthetic solution will be administrated. The depth of the fibrotomy should be equal to the amount of tooth that need to be extruded.

  • supracrustal fibrotomy will be performed using 15 c blade (Carvalho, Bauer et al. 2006)

The amount of tooth that need to be extruded will be measured Bonding brackets slot 0,022"x0.028" Roth prescription on piggyback for the tooth with (0.016". x 0.022 ") stainless steel main arch wire and 0.0014" nickel titanium auxiliary.

• Fiberotomy After 2 days of bonding, local anaesthetic solution will be administrated. The depth of the fibrotomy should be equal to the amount of tooth that need to be extruded.

supracrustal fibrotomy will be performed using 15 c blade (Carvalho, Bauer et al. 2006)

Active Comparator: laser circumferential supracrestal fiberotomy
  • The amount of tooth that need to be extruded will be measured
  • Bonding brackets slot 0,022"x0.028" Roth prescription
  • piggyback for the tooth with (0.016". x 0.022 ") stainless steel main arch wire and 0.0014" nickel titanium auxiliary.

    • Fiberotomy

  • After 2 days of bonding, local anaesthetic solution will be administrated.
  • The depth of the fibrotomy should be equal to the amount of tooth that need to be extruded.
  • A diode laser of 980 nm wavelength will be used The laser tip will be inserted, and incision will be extended around tooth circumference with the system configured to a continuous wave with the movement of the laser tip in an up and down stroking movement The laser tip will be moved in a circumferential manner taking care that all the fibers are lysed.
  • The amount of tooth that need to be extruded will be measured
  • Bonding brackets slot 0,022"x0.028" Roth prescription
  • piggyback for the tooth with (0.016". x 0.022 ") stainless steel main arch wire and 0.0014" nickel titanium auxiliary.

    • Fiberotomy

  • After 2 days of bonding, local anaesthetic solution will be administrated.
  • The depth of the fibrotomy should be equal to the amount of tooth that need to be extruded.
  • A diode laser of 980 nm wavelength will be used The laser tip will be inserted, and incision will be extended around tooth circumference with the system configured to a continuous wave with the movement of the laser tip in an up and down stroking movement The laser tip will be moved in a circumferential manner taking care that all the fibers are lysed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stability of amount of healthy tooth structure exposed
Time Frame: 8 weeks after retention.

Amount of healthy tooth structure exposed:

This is measured from the 6 guide marks in the acrylic stent around the extruded teeth to the healthy tooth structure using UNC periodontal probe in millimeters.

8 weeks after retention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stability of gingival Margin
Time Frame: 8 weeks after retention.
This is measured from the 6 guide marks in the acrylic stent around the extruded teeth to the gingival margin using UNC periodontal probe in millimeters.
8 weeks after retention.
Stability of the alveolar bone
Time Frame: 8 weeks after retention.

This is measured from the 6 guide marks in the acrylic stent around the extruded teeth to the top of the alveolar crest using UNC periodontal probe in millimeters.

This is done after administration of local anesthesia by infiltration around the tooth

8 weeks after retention.
Rate of tooth extrusion
Time Frame: 8 weeks after retention.
This is measured by calculating the average tooth extrusion per week by dividing the amount of healthy tooth structure exposed on the number of weeks.
8 weeks after retention.
Sulcus depth
Time Frame: 8 weeks after retention.
The distance from gingival margin to the base of the sulcus in millimetres.
8 weeks after retention.
Post operative pain
Time Frame: 8 weeks after retention.
VAS scale
8 weeks after retention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Nesma M Shemais, PhD, Cairo University
  • Study Director: Heba A Akl, PhD, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2023

Primary Completion (Estimated)

June 1, 2024

Study Completion (Estimated)

September 1, 2024

Study Registration Dates

First Submitted

July 11, 2023

First Submitted That Met QC Criteria

January 22, 2024

First Posted (Actual)

January 24, 2024

Study Record Updates

Last Update Posted (Actual)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 25, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 7-12-22

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Crown Lengthening

3
Subscribe